These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22377295)

  • 1. [Protecting vascular integrity in acute myocardial ischemia-reperfusion].
    Galaup A; Germain S
    Med Sci (Paris); 2012 Feb; 28(2):133-5. PubMed ID: 22377295
    [No Abstract]   [Full Text] [Related]  

  • 2. Lethal reperfusion injury in acute myocardial infarction: facts and unresolved issues.
    Garcia-Dorado D; Ruiz-Meana M; Piper HM
    Cardiovasc Res; 2009 Jul; 83(2):165-8. PubMed ID: 19502282
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathology of acute myocardial infarction: definition, location, pathogenesis, effects of reperfusion, complications, and sequelae.
    Waller BF
    Cardiol Clin; 1988 Feb; 6(1):1-28. PubMed ID: 3048670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
    Rao Y; Wang YL; Zhang WS; Liu J
    Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orphan targets for reperfusion injury.
    Inserte J; Barrabés JA; Hernando V; Garcia-Dorado D
    Cardiovasc Res; 2009 Jul; 83(2):169-78. PubMed ID: 19351740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial protection: is primary PCI enough?
    Hausenloy DJ; Yellon DM
    Nat Clin Pract Cardiovasc Med; 2009 Jan; 6(1):12-3. PubMed ID: 18852713
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of cardioprotection with ageing.
    Boengler K; Schulz R; Heusch G
    Cardiovasc Res; 2009 Jul; 83(2):247-61. PubMed ID: 19176601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac protection takes off.
    Piper HM; Garcia-Dorado D
    Cardiovasc Res; 2009 Jul; 83(2):163-4. PubMed ID: 19509028
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocardial protection against reperfusion injury: the cGMP pathway.
    Garcia-Dorado D; Agulló L; Sartorio CL; Ruiz-Meana M
    Thromb Haemost; 2009 Apr; 101(4):635-42. PubMed ID: 19350105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emulsified intravenous versus evaporated inhaled isoflurane for heart protection: old wine in a new bottle or true innovation?
    Lucchinetti E; Schaub MC; Zaugg M
    Anesth Analg; 2008 May; 106(5):1346-9. PubMed ID: 18420843
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of time to therapy and presence of collaterals on the efficacy of FX06 in acute ST elevation myocardial infarction: a substudy of the F.I.R.E., the Efficacy of FX06 in the prevention of myocardial reperfusion injury trial.
    Hallén J; Petzelbauer P; Schwitter J; Geudelin B; Buser P; Atar D
    EuroIntervention; 2010 Apr; 5(8):946-52. PubMed ID: 20542780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction with spontaneous reperfusion in a young woman with hypertrophic cardiomyopathy.
    Gori F; Pedemonte E; Nesi G
    Cardiovasc Pathol; 2006; 15(3):174-5. PubMed ID: 16697935
    [No Abstract]   [Full Text] [Related]  

  • 13. Protective effect of FK506 on myocardial ischemia/reperfusion injury by suppression of CaN and ASK1 signaling circuitry.
    Feng X; Li J; Liu J; Jin M; Liu X; Du H; Zhang L; Sun Z; Li X
    Cardiovasc Toxicol; 2011 Mar; 11(1):18-27. PubMed ID: 21076890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postconditioning: reperfusion of "reperfusion injury" after hibernation.
    Garcia-Dorado D; Piper HM
    Cardiovasc Res; 2006 Jan; 69(1):1-3. PubMed ID: 16337162
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term inhibition of myocardial infarction by postconditioning during reperfusion.
    Mykytenko J; Kerendi F; Reeves JG; Kin H; Zatta AJ; Jiang R; Guyton RA; Vinten-Johansen J; Zhao ZQ
    Basic Res Cardiol; 2007 Jan; 102(1):90-100. PubMed ID: 17003965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of myocardial infarction: protection by ischemic pre- and postconditioning.
    Skyschally A; Schulz R; Heusch G
    Herz; 2008 Mar; 33(2):88-100. PubMed ID: 18344027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion.
    Ondrejcakova M; Ravingerova T; Bakos J; Pancza D; Jezova D
    Can J Physiol Pharmacol; 2009 Feb; 87(2):137-42. PubMed ID: 19234577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin reduces postischemic coronary dysfunction: ultrastructural and functional findings after acute administration.
    Di Napoli P; Di Muzio M; Maggi A; Taccardi AA; Conti P; Barsotti A
    Microvasc Res; 2000 Jan; 59(1):181-5. PubMed ID: 10625587
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.